September 24, 2007 - VeriChip Corporation (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, and Digital Angel Corporation (AMEX: DOC), owner of Patent No. 7,125,382 for an embedded bio-sensor system, announced they have entered into a memorandum of understanding with RECEPTORS LLC, an expert in the field of proteomics and the development of artificial receptors to develop a prototype renewable glucose sensor to use in conjunction with an implantable bio-sensing RFID microchip to measure glucose levels in the human body. 
VeriChip will manage the partnership project, with the assistance of Digital Angel, aimed at accelerating the development of an embedded glucose bio-sensing system for humans. RECEPTORS will be responsible for demonstrating a self-contained glucose-sensing system in Phase I of the project...VeriChip's Press Release - Digital Angel's press Release - RECEPTORS' Press release [PDF] -
